SEC Form 4 · accession 0001078782-18-000168
Zivo Bioscience, Inc. · ZIVO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher D. Maggiore
Director · 10% Owner
Period of report
Feb 6, 2018
Accepted (ET)
Feb 14, 2018 · 6:20 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001101026
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 6, 2018 | P | 51,000 | $0.10 | A | 14,365,831 | D | |
| Common Stock | Feb 9, 2018 | P | 55,000 | $0.08 | A | 14,420,831 | D | |
| Common Stock | Feb 12, 2018 | P | 5,000 | $0.12 | A | 14,425,831 | D | |
| Common Stock | Feb 14, 2018 | P | 5,000 | $0.11 | A | 14,430,831 | D |
Table II — derivative securities
No Table II lines on this filing.